Related Experiment Videos

New drug developments for opportunistic infections in immunosuppressed patients: Pneumocystis carinii

¹Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis 46202, USA.

Journal of Medicinal Chemistry

|November 24, 1995

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Trimethoprim resistance of dihydrofolate reductase variants from clinical isolates of Pneumocystis jirovecii.

Antimicrobial agents and chemotherapy·2013

Comparison of ternary complexes of Pneumocystis carinii and wild-type human dihydrofolate reductase with coenzyme NADPH and a novel classical antitumor furo[2,3-d]pyrimidine antifolate.

Acta crystallographica. Section D, Biological crystallography·2004

Synthesis of 2,4-diamino-6-(thioarylmethyl)pyrido[2,3-d]pyrimidines as dihydrofolate reductase inhibitors.

Bioorganic & medicinal chemistry·2001

N,N'-bis[4-(N-alkylamidino)phenyl]homopiperazines as anti-Pneumocystis carinii agents.

Bioorganic & medicinal chemistry letters·2001

Isolation of rat dihydrofolate reductase gene and characterization of recombinant enzyme.

Antimicrobial agents and chemotherapy·2001

Structural studies on bioactive compounds. 34. Design, synthesis, and biological evaluation of triazenyl-substituted pyrimethamine inhibitors of Pneumocystis carinii dihydrofolate reductase.

Journal of medicinal chemistry·2001

See all related articles